| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 108.72B | 138.07B | 110.54B | 107.42B | 114.46B | 96.47B |
| Gross Profit | 10.56B | 14.45B | 10.50B | 9.71B | 8.74B | 4.81B |
| EBITDA | 3.68B | 6.35B | 3.98B | 3.82B | 3.34B | -383.00M |
| Net Income | 2.53B | 4.38B | 2.90B | 2.65B | 1.92B | -1.59B |
Balance Sheet | ||||||
| Total Assets | 80.00B | 100.78B | 80.67B | 80.62B | 79.67B | 82.19B |
| Cash, Cash Equivalents and Short-Term Investments | 27.63B | 30.96B | 20.96B | 26.23B | 27.90B | 27.05B |
| Total Debt | 674.00M | 50.00M | 952.00M | 1.17B | 1.15B | 1.18B |
| Total Liabilities | 35.84B | 49.39B | 36.21B | 38.45B | 41.83B | 46.61B |
| Stockholders Equity | 42.56B | 49.75B | 42.84B | 40.66B | 36.56B | 34.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.14B | -4.64B | -2.39B | 1.85B | 9.92B |
| Operating Cash Flow | 0.00 | 10.42B | -4.38B | -2.09B | 2.17B | 11.52B |
| Investing Cash Flow | 0.00 | 548.00M | -398.00M | -28.00M | -256.00M | -2.68B |
| Financing Cash Flow | 0.00 | -1.92B | -891.00M | -801.00M | -776.00M | -5.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥45.23B | 10.32 | ― | 1.96% | 24.91% | 51.00% | |
73 Outperform | ¥41.20B | 8.82 | ― | 3.97% | -3.24% | 60.95% | |
70 Outperform | ¥46.41B | 11.14 | ― | 3.78% | 24.67% | 72.89% | |
66 Neutral | ¥66.03B | 14.37 | ― | 3.84% | -2.49% | 23.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥61.81B | 14.53 | ― | 1.57% | 4.01% | 21.41% | |
60 Neutral | ¥25.33B | 7.14 | ― | 2.04% | -2.55% | 1.79% |